Recent advances in understanding dengue.


Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2019
Historique:
accepted: 22 07 2019
entrez: 27 8 2019
pubmed: 27 8 2019
medline: 7 5 2020
Statut: epublish

Résumé

This is a selective review of recent publications on dengue clinical features, epidemiology, pathogenesis, and vaccine development placed in a context of observations made over the past half century. Four dengue viruses (DENVs) are transmitted by urban cycle mosquitoes causing diseases whose nature and severity are influenced by interacting factors such as virus, age, immune status of the host, and human genetic variability. A phenomenon that controls the kinetics of DENV infection, antibody-dependent enhancement, best explains the correlation of the vascular permeability syndrome with second heterotypic DENV infections and infection in the presence of passively acquired antibodies. Based on growing evidence

Identifiants

pubmed: 31448083
doi: 10.12688/f1000research.19197.1
pmc: PMC6676504
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Dengue Vaccines 0
NS1 protein, dengue-1 virus 0
Viral Nonstructural Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

Références

Science. 1988 Jan 29;239(4839):476-81
pubmed: 3277268
Vaccine. 2017 Aug 24;35(36):4659-4669
pubmed: 28757058
Lancet. 2014 Oct 11;384(9951):1358-65
pubmed: 25018116
J Virol. 2000 Apr;74(7):3011-9
pubmed: 10708415
J Infect Dis. 1973 Jul;128(1):15-22
pubmed: 4198024
J Virol. 2017 Feb 14;91(5):
pubmed: 28031369
PLoS Negl Trop Dis. 2017 Apr 27;11(4):e0005498
pubmed: 28448490
PLoS Pathog. 2017 Feb 27;13(2):e1006220
pubmed: 28241052
PLoS Negl Trop Dis. 2018 Feb 15;12(2):e0006202
pubmed: 29447178
J Virol. 2015 Jan;89(1):120-8
pubmed: 25320311
J Infect Dis. 2012 Aug 1;206(3):389-98
pubmed: 22615312
Evid Based Med. 2017 Dec;22(6):225
pubmed: 29097447
Lancet Infect Dis. 2010 Oct;10(10):712-22
pubmed: 20883967
Virology. 2007 Feb 20;358(2):402-12
pubmed: 17014880
Adv Virus Res. 2008;72:1-76
pubmed: 19081488
Am J Trop Med Hyg. 2018 Feb;98(2):402-409
pubmed: 29313471
J Pediatr. 2003 Nov;143(5):682-4
pubmed: 14615749
Yale J Biol Med. 1970 Apr;42(5):350-62
pubmed: 5419208
PLoS Negl Trop Dis. 2016 Aug 24;10(8):e0004939
pubmed: 27556807
J Virol. 2017 Feb 14;91(5):
pubmed: 27974563
J Infect Dis. 2017 Mar 15;215(6):992-999
pubmed: 28453844
EBioMedicine. 2017 Jun;20:202-216
pubmed: 28483582
Cell Rep. 2019 Feb 5;26(6):1598-1613.e8
pubmed: 30726741
Front Immunol. 2016 Dec 07;7:531
pubmed: 28003809
Viruses. 2011 Sep;3(9):1562-608
pubmed: 21994796
J Infect Dis. 2016 Sep 15;214(6):832-5
pubmed: 26908742
Vector Borne Zoonotic Dis. 2019 Sep;19(9):685-689
pubmed: 30964397
J Infect Dis. 2002 May 1;185(9):1213-21
pubmed: 12001037
BMC Med Genet. 2018 Feb 13;19(1):23
pubmed: 29439659
Trop Med Int Health. 2019 Apr;24(4):442-453
pubmed: 30624838
N Engl J Med. 2015 Jan 8;372(2):113-23
pubmed: 25365753
Sci Transl Med. 2015 Sep 9;7(304):304ra141
pubmed: 26355030
Clin Sci (Lond). 2000 Feb;98(2):211-6
pubmed: 10657278
Infect Genet Evol. 2018 Aug;62:279-295
pubmed: 29704626
J Infect Dis. 2019 Jun 19;220(2):219-227
pubmed: 30895307
Front Immunol. 2017 Oct 13;8:1309
pubmed: 29081779
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
J Virol. 2011 Feb;85(4):1671-83
pubmed: 21123382
PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2592
pubmed: 24349598
Vaccine. 2015 Nov 17;33(46):6351-9
pubmed: 26384447
Semin Immunopathol. 2017 Jul;39(5):563-574
pubmed: 28401256
Lancet Glob Health. 2018 Feb;6(2):e140-e141
pubmed: 29389533
J Infect Dis. 2006 Apr 15;193(8):1078-88
pubmed: 16544248
Vaccine. 2011 Sep 23;29(42):7251-60
pubmed: 21777638
BMC Public Health. 2015 Mar 14;15:250
pubmed: 25886528
PLoS Pathog. 2018 May 3;14(5):e1006965
pubmed: 29723307
F1000Res. 2015 Nov 25;4:
pubmed: 26918141
PLoS Negl Trop Dis. 2013 Sep 26;7(9):e2462
pubmed: 24086788
J Infect Dis. 2000 Jan;181(1):2-9
pubmed: 10608744
Proc Biol Sci. 2016 Jul 13;283(1834):
pubmed: 27412286
Vaccine. 1996 Mar;14(4):329-36
pubmed: 8744561
J Virol. 2005 Sep;79(17):11403-11
pubmed: 16103191
PLoS Pathog. 2016 Jul 14;12(7):e1005738
pubmed: 27416066
Nat Microbiol. 2019 May;4(5):854-863
pubmed: 30833735
PLoS Negl Trop Dis. 2013 May 30;7(5):e2243
pubmed: 23738026
Front Immunol. 2014 Apr 10;5:151
pubmed: 24782859
PLoS Pathog. 2014 Apr 03;10(4):e1004031
pubmed: 24699622
J Clin Virol. 2015 Aug;69:63-7
pubmed: 26209381
Wkly Epidemiol Rec. 2016 May 27;91(21):266-84
pubmed: 27236869
J Infect Dis. 2015 Dec 1;212(11):1743-51
pubmed: 25980035
Viruses. 2011 Oct;3(10):1800-14
pubmed: 22069516
Clin Infect Dis. 2013 Dec;57(11):1577-86
pubmed: 24046311
Cell Rep. 2018 Oct 30;25(5):1214-1224
pubmed: 30380413
Am J Trop Med Hyg. 2016 Jun 1;94(6):1342-7
pubmed: 27022151
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):227-232
pubmed: 30518559
Lancet Infect Dis. 2014 Sep;14(9):830-8
pubmed: 25087476
Expert Rev Vaccines. 2016;15(4):497-508
pubmed: 26635182
J Virol. 2000 Apr;74(7):3020-8
pubmed: 10708416
Virology. 1997 Apr 14;230(2):300-8
pubmed: 9143286
Lancet. 2017 Apr 22;389(10079):1611-1618
pubmed: 28283286
Elife. 2017 Sep 05;6:
pubmed: 28871961
PLoS Negl Trop Dis. 2018 Dec 17;12(12):e0006975
pubmed: 30557313
Sci Transl Med. 2016 Mar 16;8(330):330ra36
pubmed: 27089205
PLoS Negl Trop Dis. 2012;6(6):e1679
pubmed: 22745839
Elife. 2019 Apr 08;8:
pubmed: 30958263
Lancet. 2007 Apr 28;369(9571):1452-1459
pubmed: 17467515
J Virol Methods. 2018 Jul;257:48-57
pubmed: 29567514
J Infect. 2010 Mar;60(3):229-37
pubmed: 20080126
PLoS Pathog. 2019 Apr 22;15(4):e1007625
pubmed: 31009511
Nature. 2018 May;557(7707):719-723
pubmed: 29795354
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14688-93
pubmed: 26553981
Adv Virus Res. 2003;60:421-67
pubmed: 14689700
PLoS One. 2019 Jan 25;14(1):e0210041
pubmed: 30682037
Bioscience. 2018 Nov 1;68(11):854-860
pubmed: 30464351
J Infect. 2012 Mar;64(3):325-34
pubmed: 22138554
J Clin Virol. 2015 Mar;64:160-73
pubmed: 25453327
Science. 2017 Nov 17;358(6365):929-932
pubmed: 29097492
Int J Infect Dis. 2012 Mar;16(3):e198-203
pubmed: 22277259
J Infect Dis. 2017 Feb 1;215(3):351-358
pubmed: 27932620
PLoS Negl Trop Dis. 2015 Dec 11;9(12):e0004262
pubmed: 26658730
Infect Genet Evol. 2017 Dec;56:99-110
pubmed: 29133029
PLoS Negl Trop Dis. 2017 Jul 10;11(7):e0005740
pubmed: 28692675
PLoS Pathog. 2017 Nov 9;13(11):e1006673
pubmed: 29121099
PLoS Negl Trop Dis. 2012;6(6):e1716
pubmed: 22745847
J Infect Dis. 2014 Feb 1;209(3):360-8
pubmed: 23964110
J Infect Dis. 2013 Jun 15;207(12):1898-908
pubmed: 23526830
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):994-9
pubmed: 23277539
Am J Epidemiol. 1984 Nov;120(5):653-69
pubmed: 6496446
J Med Virol. 2003 Jan;69(1):82-90
pubmed: 12436482
Trop Med Int Health. 2016 Mar;21(3):445-53
pubmed: 26752720
Lancet Glob Health. 2018 May;6(5):e495
pubmed: 29653620
J Infect Dis. 2015 Sep 1;212(5):702-10
pubmed: 25801652
Southeast Asian J Trop Med Public Health. 2005 Jan;36(1):178-85
pubmed: 15906664
Parasit Vectors. 2013 Dec 12;6:351
pubmed: 24330720
Emerg Infect Dis. 2009 Aug;15(8):1265-70
pubmed: 19751589
J Immunol. 2019 Feb 15;202(4):1153-1162
pubmed: 30642979
N Engl J Med. 2018 Jul 26;379(4):327-340
pubmed: 29897841
Rev Panam Salud Publica. 2002 Apr;11(4):223-7
pubmed: 12049030
Rev Med Virol. 2018 Nov;28(6):e2005
pubmed: 30109914
Am J Trop Med Hyg. 2018 Nov;99(5):1299-1307
pubmed: 30226138
J Clin Microbiol. 2000 Mar;38(3):1053-7
pubmed: 10698995
PLoS Negl Trop Dis. 2010 Apr 13;4(4):e657
pubmed: 20405057
J Infect Dis. 2013 Mar 15;207(6):957-65
pubmed: 23329850
Emerg Infect Dis. 2007 Feb;13(2):282-6
pubmed: 17479892
J Biomed Sci. 2018 Nov 8;25(1):77
pubmed: 30409217
Expert Rev Vaccines. 2016;15(4):509-17
pubmed: 26559731
Nat Med. 2003 Jul;9(7):921-7
pubmed: 12808447
Am J Trop Med Hyg. 2007 Nov;77(5):910-3
pubmed: 17984352
Sci Transl Med. 2015 Sep 9;7(304):304ra142
pubmed: 26355031
Am J Trop Med Hyg. 1969 Nov;18(6):954-71
pubmed: 5355242
Front Immunol. 2014 Jun 11;5:280
pubmed: 24966859
EBioMedicine. 2016 Nov;13:284-293
pubmed: 27746192
J Virol. 2015 Jul;89(14):7348-62
pubmed: 25972550
PLoS Negl Trop Dis. 2009 Jul 21;3(7):e481
pubmed: 19621090
Emerg Infect Dis. 2002 Dec;8(12):1474-9
pubmed: 12498666
Sci Rep. 2017 Apr 10;7:46191
pubmed: 28393899
Lancet. 2012 Nov 3;380(9853):1559-67
pubmed: 22975340
Bull World Health Organ. 1966;35(1):3-15
pubmed: 5297536
Yale J Biol Med. 1970 Apr;42(5):311-28
pubmed: 5419206
Trans R Soc Trop Med Hyg. 2017 Oct 1;111(10):433-439
pubmed: 29385613
Hum Pathol. 2014 Jun;45(6):1221-33
pubmed: 24767772
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263304
J Gen Virol. 1987 Mar;68 ( Pt 3):853-7
pubmed: 3819700
N Engl J Med. 2015 Sep 24;373(13):1195-206
pubmed: 26214039
J Infect Dis. 2008 Aug 15;198(4):516-24
pubmed: 18598189
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63
pubmed: 26195744
Rev Inst Med Trop Sao Paulo. 2018 Aug 20;60:e43
pubmed: 30133603
Am J Trop Med Hyg. 2013 Dec;89(6):1081-7
pubmed: 24127167
Am J Trop Med Hyg. 1952 Jan;1(1):30-50
pubmed: 14903434
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8378-E8387
pubmed: 30127007
J Clin Virol. 2015 Aug;69:91-5
pubmed: 26209387

Auteurs

Scott Halstead (S)

Emeritus Professor, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH